Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01310270 · ClinicalTrials.gov registry record · NA
The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT01310270: Completed NA study, sponsored by University of California, San Francisco.
NCT01310270 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01310270, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
The hypothesis being tested is that in patients with stable claudication and documented PAD, omega-3 supplementation for 1 month will lead to improvement in endothelial function as measured by flow-mediated, brachial artery vasodilation (FMD), as well as improvement in the vascular inflammatory profile as measured by a panel of established circulating inflammatory biomarkers.
Primary Outcome
Flow-mediated, brachial artery vasodilation (FMD)
Interventions
- DIETARY_SUPPLEMENT Pro-Omega
- DIETARY_SUPPLEMENT Omega 3 Fatty Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2011-04 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT01310270 record still lists
NCT01310270 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Pro-Omega is the first listed.
NCT01310270 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01310270 about?
NCT01310270 is a clinical study titled "The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation". The hypothesis being tested is that in patients with stable claudication and documented PAD, omega-3 supplementation for 1 month will lead to improvement in endothelial function as measured by flow-mediated, brachial artery vasodilation (FMD), as well as improvement in the vascular inflammatory prof...
What is the current status of trial NCT01310270?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2011-04. Estimated completion is 2018-12.
What interventions are being tested in trial NCT01310270?
The interventions under investigation include: Pro-Omega (DIETARY_SUPPLEMENT), Omega 3 Fatty Acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01310270?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01310270's enrollment target sits among peer trials
180 586th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia